Old Web
English
Sign In
Acemap
>
Paper
>
Corrigendum: SCD1 Confers Temozolomide Resistance to Human Glioma Cells Via the Akt/GSK3β/β-Catenin Signaling Axis
Corrigendum: SCD1 Confers Temozolomide Resistance to Human Glioma Cells Via the Akt/GSK3β/β-Catenin Signaling Axis
2019
Shuang Dai
Yuanliang Yan
Zhijie Xu
Shuangshuang Zeng
Long Qian
Lei Huo
Xuejun Li
Lunquan Sun
Zhicheng Gong
Keywords:
Pharmacology
Diabetes mellitus
Temozolomide
Medicine
Protein kinase B
Catenin
Glioma
akt gsk3β
β catenin signaling
human glioma
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]